|
Name |
1-Allylcyclopropanecarboxylic acid
|
| Molecular Formula | C7H10O2 | |
| IUPAC Name* |
1-prop-2-enylcyclopropane-1-carboxylic acid
|
|
| SMILES |
C=CCC1(CC1)C(=O)O
|
|
| InChI |
InChI=1S/C7H10O2/c1-2-3-7(4-5-7)6(8)9/h2H,1,3-5H2,(H,8,9)
|
|
| InChIKey |
YCHKQUJFRCYZQT-UHFFFAOYSA-N
|
|
| Synonyms |
1-Allylcyclopropanecarboxylic acid; 80360-57-2; 1-(prop-2-en-1-yl)cyclopropane-1-carboxylic acid; 1-prop-2-enylcyclopropane-1-carboxylic acid; Cyclopropanecarboxylic acid, 1-(2-propenyl)-; SCHEMBL517571; 1-Allylcyclopropanecarboxylicacid; DTXSID80339542; (2-propenyl)cyclopropanecarboxylic; AMY34534; MFCD12026354; ZINC32225553; AKOS006318226; 1-allyl-cyclopropane-1-carboxylic acid; PB47942; TS-01659; CS-0052808; EN300-175757; P17143; F8885-0920
|
|
| CAS | 80360-57-2 | |
| PubChem CID | 556871 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 126.15 | ALogp: | 1.2 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
| Heavy Atoms: | 9 | QED Weighted: | 0.587 |
| Caco-2 Permeability: | -4.892 | MDCK Permeability: | 0.00001900 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.086 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.423 | Plasma Protein Binding (PPB): | 55.61% |
| Volume Distribution (VD): | 0.462 | Fu: | 55.07% |
| CYP1A2-inhibitor: | 0.035 | CYP1A2-substrate: | 0.345 |
| CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.132 |
| CYP2C9-inhibitor: | 0.035 | CYP2C9-substrate: | 0.088 |
| CYP2D6-inhibitor: | 0.022 | CYP2D6-substrate: | 0.138 |
| CYP3A4-inhibitor: | 0.062 | CYP3A4-substrate: | 0.145 |
| Clearance (CL): | 1.038 | Half-life (T1/2): | 0.676 |
| hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.366 |
| Drug-inuced Liver Injury (DILI): | 0.018 | AMES Toxicity: | 0.058 |
| Rat Oral Acute Toxicity: | 0.754 | Maximum Recommended Daily Dose: | 0.037 |
| Skin Sensitization: | 0.036 | Carcinogencity: | 0.133 |
| Eye Corrosion: | 0.989 | Eye Irritation: | 0.99 |
| Respiratory Toxicity: | 0.875 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000639 | ![]() |
0.323 | D03QIP | ![]() |
0.250 | ||
| ENC000148 | ![]() |
0.308 | D0J0ZS | ![]() |
0.244 | ||
| ENC001220 | ![]() |
0.267 | D0R3QY | ![]() |
0.243 | ||
| ENC000896 | ![]() |
0.256 | D0M8AB | ![]() |
0.214 | ||
| ENC002417 | ![]() |
0.238 | D0Z5BC | ![]() |
0.204 | ||
| ENC000647 | ![]() |
0.217 | D04CRL | ![]() |
0.192 | ||
| ENC000058 | ![]() |
0.214 | D0X7HM | ![]() |
0.186 | ||
| ENC000022 | ![]() |
0.214 | D0C6OQ | ![]() |
0.185 | ||
| ENC003143 | ![]() |
0.206 | D02FLB | ![]() |
0.185 | ||
| ENC005922 | ![]() |
0.203 | D0DZ3X | ![]() |
0.184 | ||